SEATTLE (AP) 鈥� SEATTLE (AP) 鈥� Perspective Therapeutics, Inc. (CATX) on Monday reported a loss of $26.8 million in its second quarter.
On a per-share basis, the Seattle-based company said it had a loss of 22 cents.
The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
The isotope-based medical products maker posted revenue of $81,000 in the period.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/CATX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
